Stock listing
Calidi Biotherapeutics, Inc.
Selected listing: CLDI · AMEX · USD · US
Calidi Biotherapeutics, Inc. (NYSE American: CLDI), Health Technology. Latest release Sep 17, 2026: Calidi Biotherapeutics Announces $1.2 Million Registered…
- Ticker
- NYSE American: CLDI
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
About Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. (ticker: CLDI) is a public company operating in the American market, focusing on innovative biotherapeutic solutions. The company aims to address significant medical needs through its unique therapeutic approaches.
Latest news from Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
September 17, 2026
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 13, 2026
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
July 22, 2026
Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026
July 20, 2026
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
June 24, 2026
Research Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. company profile
View the public company page for Calidi Biotherapeutics, Inc. on 6ix.
Calidi Biotherapeutics, Inc. news
Read company news and market updates connected to Calidi Biotherapeutics, Inc..
Calidi Biotherapeutics, Inc. investor events
Find investor webinars, events, and replay context for Calidi Biotherapeutics, Inc..